Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Human Reproductive Technologies Market, by Region, 2019-2029 (USD Billion)
1.2.2. Human Reproductive Technologies Market, by Reproductive Technology, 2019-2029 (USD Billion)
1.2.3. Human Reproductive Technologies Market, by Gender, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Reproductive Technologies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Reproductive Technologies Market Dynamics
3.1. Human Reproductive Technologies Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Decreasing birth rate
3.1.1.2. Delayed family planning
3.1.2. Market Challenges
3.1.2.1. Limited insurance coverage
3.1.3. Market Opportunities
3.1.3.1. Rising infertility rate
3.1.3.2. Growing R&D activities by market players
Chapter 4. Global Human Reproductive Technologies Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Human Reproductive Technologies Market, by Reproductive Technology
6.1. Market Snapshot
6.2. Global Human Reproductive Technologies Market by Reproductive Technology Performance - Potential Analysis
6.3. Global Human Reproductive Technologies Market Estimates & Forecasts by Reproductive Technology 2019-2029 (USD Billion)
6.4. Human Reproductive Technologies Market, Sub Segment Analysis
6.4.1. Infertility drugs,
6.4.2. Contraceptive
Chapter 7. Global Human Reproductive Technologies Market, by Gender
7.1. Market Snapshot
7.2. Global Human Reproductive Technologies Market by Gender, Performance - Potential Analysis
7.3. Global Human Reproductive Technologies Market Estimates & Forecasts by Gender 2019-2029 (USD Billion)
7.4. Human Reproductive Technologies Market, Sub Segment Analysis
7.4.1. Male
7.4.2. Female
Chapter 8. Global Human Reproductive Technologies Market, Regional Analysis
8.1. Human Reproductive Technologies Market, Regional Market Snapshot
8.2. North America Human Reproductive Technologies Market
8.2.1. U.S. Human Reproductive Technologies Market
8.2.1.1. Reproductive Technology breakdown estimates & forecasts, 2019-2029
8.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Human Reproductive Technologies Market
8.3. Europe Human Reproductive Technologies Market Snapshot
8.3.1. U.K. Human Reproductive Technologies Market
8.3.2. Germany Human Reproductive Technologies Market
8.3.3. France Human Reproductive Technologies Market
8.3.4. Spain Human Reproductive Technologies Market
8.3.5. Italy Human Reproductive Technologies Market
8.3.6. Rest of Europe Human Reproductive Technologies Market
8.4. Asia-Pacific Human Reproductive Technologies Market Snapshot
8.4.1. China Human Reproductive Technologies Market
8.4.2. India Human Reproductive Technologies Market
8.4.3. Japan Human Reproductive Technologies Market
8.4.4. Australia Human Reproductive Technologies Market
8.4.5. South Korea Human Reproductive Technologies Market
8.4.6. Rest of Asia Pacific Human Reproductive Technologies Market
8.5. Latin America Human Reproductive Technologies Market Snapshot
8.5.1. Brazil Human Reproductive Technologies Market
8.5.2. Mexico Human Reproductive Technologies Market
8.6. Rest of The World Human Reproductive Technologies Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. CooperSurgical, Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Teva Pharmaceutical Industries
9.2.3. AbbVie Inc.
9.2.4. Ferring B.V.
9.2.5. Merck KGaA
9.2.6. Genea Limited
9.2.7. Ivftech
9.2.8. Bayer AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption